Arrowhead Pharma (ARWR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 09/30
| 09-2010 | 09-2009 | 09-2008 | 09-2007 | 09-2006 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -5,774 | -19,308 | -27,089 | -29,931 | -18,997 |
| Depreciation Amortization | 278 | 995 | 1,133 | 1,004 | 887 |
| Accounts receivable | -872 | -61 | 189 | -202 | -41 |
| Accounts payable and accrued liabilities | -203 | -329 | -438 | 505 | 370 |
| Other Working Capital | -902 | -825 | -233 | 41 | 1,355 |
| Other Operating Activity | 2,420 | 4,415 | -1,147 | 4,717 | 1,634 |
| Operating Cash Flow | $-5,053 | $-15,114 | $-27,585 | $-23,867 | $-14,791 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | N/A | N/A | N/A | N/A | -18,576 |
| PPE Investments | N/A | 39 | -684 | -756 | -730 |
| Net Acquisitions | N/A | N/A | 109 | N/A | N/A |
| Purchase Of Investment | N/A | N/A | -2,000 | N/A | N/A |
| Sale Of Investment | N/A | 700 | N/A | N/A | 18,968 |
| Purchase Sale Intangibles | N/A | N/A | N/A | N/A | -205 |
| Other Investing Activity | 0 | 0 | 0 | 0 | -205 |
| Investing Cash Flow | $N/A | $739 | $-2,575 | $-756 | $-542 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | 4,517 | 9,014 | 5,136 | N/A |
| Debt Repayment | N/A | -811 | -140 | N/A | N/A |
| Common Stock Issued | 12,165 | 2,759 | 7,259 | 15,587 | 20,887 |
| Financing Cash Flow | $12,165 | $6,465 | $16,133 | $20,723 | $20,887 |
| Beginning Cash Position | 2,020 | 10,094 | 24,120 | 28,020 | 22,467 |
| End Cash Position | 6,847 | 2,020 | 10,094 | 24,120 | 28,020 |
| Net Cash Flow | $4,827 | $-8,073 | $-14,027 | $-3,900 | $5,553 |
| Free Cash Flow | |||||
| Operating Cash Flow | -5,053 | -15,114 | -27,585 | -23,867 | -14,791 |
| Capital Expenditure | N/A | -40 | -684 | -756 | -730 |
| Free Cash Flow | -5,053 | -15,154 | -28,269 | -24,624 | -15,521 |